|
|
|
Oxford Global, ILEC Conference Centre, 47 Lillie Road, London, UK, SW6 1UD
20th - 21st May 2019
300+ delegates from global pharmaceutical organisations, leading biotechnology companies & world-renowned academic institutions.
50+ presentations & case studies focusing on the key developments in Immuno-Oncology from early discovery through to the clinic.
Featuring the following main themes:
• Discovery of Immuno-Oncology Therapies • Preclinical Development • Translational Immuno-Oncology • Precision Medicine and Personalised Therapy • Genomics in Cancer Immunotherapy • Immuno-Oncology Clinical Research and Clinical Trials
Free Live Webinar: Bringing Immuno-Oncology Products To Patients With Life Threatening Diseases Hosted by Katrien Reynders, Program Director, Celyad SA 14th March, 2019 | 2:00pm GMT Join us now: https://bit.ly/2tkT5qs
For further information on the congress and to receive prices and booking details, please contact me at a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
Invited Speakers:
|
|
2019 Speakers Include: - Alex Cao, Executive Director, MSD
- Tomasz Lawniczek, Senior Clinical Development Medical Director, CAR T Cell Therapy, Novartis
- Ahmadur Rahman, Senior Clinical Director Oncology, MSD
For the full line-up of speakers, please view our event website: https://bit.ly/2tDPvaQ
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
Registration:
|
|
N/A
|
|
|
|
|
|
|
|